132 related articles for article (PubMed ID: 3035846)
1. Semiquantitative cytochemical estimation of glucose-6-phosphate dehydrogenase activity in benign diseases and carcinoma of the breast.
Bokun R; Bakotin J; Milasinović D
Acta Cytol; 1987; 31(3):249-52. PubMed ID: 3035846
[TBL] [Abstract][Full Text] [Related]
2. Identification of malignant cells in primary monolayer cultures of human breast tumors.
Petersen OW; Briand P; van Deurs B
Acta Pathol Microbiol Immunol Scand A; 1984 Mar; 92(2):103-12. PubMed ID: 6322514
[TBL] [Abstract][Full Text] [Related]
3. Effect of oxygen on the tetrazolium reaction for glucose 6-phosphate dehydrogenase in cryosections of human breast carcinoma, fibrocystic disease and normal breast tissue.
Petersen OW; Høyer PE; van Deurs B
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 50(1):13-25. PubMed ID: 2867640
[TBL] [Abstract][Full Text] [Related]
4. The correlation of cytologic degree of differentiation of infiltrative ductal breast carcinoma and cytochemical activity of glucose-6-phosphate dehydrogenase.
Bokun R; Tatomirović Z
Vojnosanit Pregl; 1998; 55(4):369-72. PubMed ID: 9769735
[TBL] [Abstract][Full Text] [Related]
5. An enzyme histochemical study of some dehydrogenases in abnormal human mammary tissue.
Harcourt-Webster JN; Truman RF
J Pathol; 1969 Oct; 99(2):105-12. PubMed ID: 4311873
[No Abstract] [Full Text] [Related]
6. Peroxidase activities in human breast tumours in relation to menstrual status of the patients.
Talukdar C; Ghosh S
Indian J Med Res; 1984 Jun; 79():801-5. PubMed ID: 6097539
[No Abstract] [Full Text] [Related]
7. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of human breast carcinoma cells in cryosections and primary monolayer cultures of surgical biopsies by neotetrazolium reductase cytochemistry.
Petersen OW; van Deurs B
Cancer Res; 1986 Apr; 46(4 Pt 2):2013-20. PubMed ID: 3081261
[TBL] [Abstract][Full Text] [Related]
9. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
10. Histochemical studies of human breast tumors: Activity of alkaline phosphatase, acid phosphatase and glucose-6-phosphate dehydrogenase.
Livni N; Laufer A
Pathol Microbiol (Basel); 1975; 42(3):159-70. PubMed ID: 1187202
[TBL] [Abstract][Full Text] [Related]
11. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
12. [Possibility of using histo- and cytochemical determination of phosphorylase in the diagnosis of breast tumors].
Probatova NA; Koriakina RF
Arkh Patol; 1967; 29(2):18-22. PubMed ID: 4302650
[No Abstract] [Full Text] [Related]
13. Enzyme activities in normal, dysplastic, and cancerous human breast tissues.
Balinsky D; Platz CE; Lewis JW
J Natl Cancer Inst; 1984 Feb; 72(2):217-24. PubMed ID: 6582310
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
15. Quantitative cytochemistry of glucose-6-phosphate dehydrogenase in benign and malignant breast tumours.
Barron ET; Smyth PP; McDermott EW; Tobbia IN; Higgins NJ
Eur J Cancer; 1991; 27(8):985-9. PubMed ID: 1832909
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
[TBL] [Abstract][Full Text] [Related]
17. Increased dihydropyrimidine dehydrogenase activity in breast cancer.
Anan K; Mitsuyama S; Tamae K; Suehara N; Nishihara K; Ogawa Y; Abe Y; Iwashita T; Toyoshima S
J Surg Oncol; 2003 Mar; 82(3):174-9. PubMed ID: 12619061
[TBL] [Abstract][Full Text] [Related]
18. [Tyrosine-protein kinase activity in breast neoplasm. Comparison with activity obtained in benign diseases and in normal tissues].
Pierart J; Oñate E; Klaassen R; Cid L; Gutierrez S; Talbot E; Ross E; Zambrano C; Burmeister R; Puchi M
Rev Med Chil; 1995 Feb; 123(2):165-75. PubMed ID: 7569456
[TBL] [Abstract][Full Text] [Related]
19. Glutathione peroxidase, glutathione S-transferase and glutathione reductase activities in normal and neoplastic human breast tissue.
di Ilio C; Sacchetta P; del Boccio G; la Rovere G; Federici G
Cancer Lett; 1985 Oct; 29(1):37-42. PubMed ID: 2998588
[TBL] [Abstract][Full Text] [Related]
20. Proceedings: Correlations between certain biochemical properties of breast cancer and response to therapy: a preliminary report.
Savlov ED; Wittliff JL; Hilf R; Hall TC
Cancer; 1974 Feb; 33(2):303-9. PubMed ID: 4360053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
